
|Articles|April 25, 2023
Almac Announces Launch of IXRS®3 Partnership Network
Advertisement
Almac Clinical Technologies, a member of the Almac Group, has announced the launch of its IXRS®3 Partnership Network for biopharmaceutical sponsors, which aims to accelerate the development and delivery of eClinical solutions.
This Partnership Network gives sponsors and CROs the opportunity to share data and solutions to build a more inclusive clinical trial experience for all sites and patients.
Reference
Almac Announces Launch of IXRS®3 Partnership Network. (2023, April 25). Almac.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
From Participation to Understanding: Reframing Engagement in Clinical Trials
2
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
3
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
4
ACT Brief: RBQM Multi-Functional Buy-In and E6(R3), Site Payment Performance and Cash Runway, and Inhaled Therapy for Cystic Fibrosis
5




